vancomycin has been researched along with Infections, Staphylococcal Skin in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.20) | 18.7374 |
1990's | 2 (2.41) | 18.2507 |
2000's | 30 (36.14) | 29.6817 |
2010's | 47 (56.63) | 24.3611 |
2020's | 3 (3.61) | 2.80 |
Authors | Studies |
---|---|
Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
Abbanat, D; Bush, K; Fernandez, J; Goldschmidt, R; Hilliard, JJ; Macielag, MJ; Melton, J | 1 |
Hurdle, JG; Lee, RE; Sun, D; Yendapally, R | 1 |
Bao, R; He, L; Ju, Y; Li, C; Luo, Y; Sang, Z; Song, R; Sun, K; Yang, T; Yang, Y; Zhou, Y | 1 |
Habib, A; Qadir, A | 1 |
Ahmadvand, D; Alikhani, MY; Arabestani, MR; Hajiahmadi, F; Shariatifar, H | 1 |
Brescini, L; Cirioni, O; Giacometti, A; Lazzarini, R; Lucarini, G; Morroni, G; Offidani, A; Orlando, F; Provinciali, M; Simonetti, O; Zizzi, A | 1 |
Bavya, MC; George, L; Rohan, KV; Srivastava, R | 1 |
Charrier, C; Hawser, S; Huang, DB; Le Bras, C; Noviello, S | 1 |
Frimodt-Møller, N; Vingsbo Lundberg, C | 1 |
Baek, JY; Chung, DR; Kang, CI; Kim, SH; Ko, J; Lee, NY; Park, SY; Peck, KR; Song, JH | 1 |
Biswas, P; Capitano, B; Duane, TM; Joshi, M; Puzniak, LA | 1 |
Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA | 1 |
Biswas, P; Capitano, B; Lodise, TP; Puzniak, LA | 1 |
Calandra, T; Greub, G; Prod'hom, G; Senn, L; Taffe, P; Tissot, F; Zanetti, G | 1 |
Chambers, R; Charbonneau, C; Eckmann, C; Haider, S; Hajek, P; Lawson, W; Li, JZ; Macahilig, C; Nathwani, D; Simoneau, D; Solem, CT; Stephens, JM | 1 |
Bashline, B; LaFond, A; Morrison, M; Ramirez, J | 1 |
Datta, V; Hamilton, M; Hilliard, JJ; Jones-Nelson, O; Nguyen, V; O'Day, T; Prokai, L; Sadowska, A; Sellman, BR; Stover, CK; Suzich, J; Szarka, S; Tkaczyk, C; Weiss, WJ | 1 |
Chen, SJ; Chou, YL; Hsieh, KH; Lo, WT; Wang, CC | 1 |
Baillon-Plot, N; Charbonneau, C; Corman, S; Eckmann, C; Haider, S; Lawson, W; Li, J; Macahilig, C; Nathwani, D; Solem, C; Stephens, J | 2 |
Balbuena Segura, AI; Corrales Fernández, MJ; Gea Velázquez de Castro, MT | 1 |
Bernardino, V; Panarra, A; Riso, N; Rodrigues, A | 1 |
Fermann, G; Hart, K; Korfhagen, J; Lindsell, CJ; Meunier, JM; Shaw, GJ; Wayne, B | 1 |
Budimir, A | 1 |
Baba-Honda, H; Miyake, S; Nakagawa, H; Nobeyama, Y | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Changchien, CH; Chen, SW; Chen, YY; Chu, C | 1 |
Chen, Y; Dong, DP; Gu, FF; Guo, XK; Han, LZ; Ni, YX; Song, Z | 1 |
Barriere, SL; Corey, GR; Smart, JI; Stryjewski, ME; Wang, W | 1 |
Kapp, A; Mai, U; Niebuhr, M; Werfel, T | 1 |
Abazia, DT; Marcus, A; Ross, J; Sachinwalla, E; Smolarz, BG | 1 |
Buckwalter, M; Damle, B; Dowell, JA; Goldstein, BP; Stogniew, M | 1 |
da Silva, LV; de Souza, MV; Marcadenti, A; Zavascki, AP | 1 |
Barriere, SL; Kuti, JL; Laohavaleeson, S; Nicolau, DP | 1 |
Bounthavong, M; Hsu, DI; Okamoto, MP | 1 |
Akhras, KS; Budd, D; Itani, KM; Merchant, S; Quintana, A; Stellhorn, R | 1 |
Carson, RT; Friedman, M; Marton, JP; Menzin, J; Meyers, JL; Rothermel, CD | 1 |
Bae, IG; Barriere, SL; Corey, GR; Fowler, VG; Genter, FC; Reilly, LF; Rude, TH; Stryjewski, ME; Tonthat, GT | 1 |
Dodds, TJ; Hawke, CI | 1 |
Chambers, HF; Deshpande, LM; Diep, BA; Jones, RN; Mendes, RE; Sader, HS | 1 |
Bounthavong, M; Hsu, DI | 2 |
Fey, PD; Olson, ME; Rupp, ME; Slater, SR | 1 |
Bertuccio, T; Bongiorno, D; Borbone, S; Cafiso, V; Campanile, F; Nicolosi, D; Perez, M; Purrello, S; Scuderi, C; Stefani, S | 1 |
Barriere, SL; Benton, BM; Kitt, MM; Krause, KM | 1 |
Aleo, A; Bonura, C; Calà, C; di Carlo, P; Mammina, C; Monastero, R; Palma, DM | 1 |
Barriere, SL | 1 |
Frei, CR; Lawson, KA; Lewis, JS; Miller, ML; Peddaiahgari, R; Talbert, RL | 1 |
Jones, RN; Mendes, RE; Pfaller, MA; Rhomberg, PR; Sader, HS | 1 |
Huang, DB; Itani, KM; Joseph, W; Lipsky, BA; Myers, DE; Paap, CM; Reisman, A; Weigelt, JA | 1 |
Diamantis, ML; Morrell, DS; Ortega-Loayza, AG | 1 |
Hedge, DD; Hellwig, TR; Laible, BR | 1 |
Chaves, RL; Fierlbeck, G; Loeffler, J; Quist, SR; Seaton, RA | 1 |
Duane, TM; Huang, DB; Puzniak, LA; Weigelt, JA | 1 |
Ahn, SH; Biek, D; Critchley, I; Fowler, VG; Lamlertthon, S; Llorens, L; Rude, T; Ruffin, F; Sharma-Kuinkel, BK; Tamarana, G; Tong, A; Tong, SY; Zhang, Y | 1 |
Baruch, AM; Bhattacharyya, H; Biswas, P; Itani, KM; Reisman, A | 1 |
Bloomberg, GR; Cooper, MA; Dehner, LP; Heidingsfelder, JA; Kitcharoensakkul, M; Ree, N; White, AJ | 1 |
Aikawa, N; Kato, Y; Kusachi, S; Mikamo, H; Morita, A; Takesue, Y; Tanaka, Y; Tsumori, K; Watanabe, S; Yoshinari, T | 1 |
Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
Anik, S; Beasley, FC; Borkowski, AW; Dorrestein, PC; Gonzalez, DJ; Gusarov, I; Nizet, V; Nudler, E; van Sorge, NM; von Köckritz-Blickwede, M | 1 |
Arhin, FF; Moeck, G; Sarmiento, I | 1 |
Balaban, N; Cirioni, O; D'Amato, G; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Gov, Y; Kamysz, W; Lukasiak, J; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G | 1 |
Dissemond, J; Esser, S; Goos, M | 1 |
Dissemond, J; Esser, S; Goos, M; Schmid, EN; Witthoff, M | 1 |
Cohen, PR; Grossman, ME | 1 |
Lipsky, BA; Stoutenburgh, U | 1 |
Duttagupta, S; Itani, KM; Li, JZ; Weigelt, J | 1 |
Stevens, DL | 1 |
Scheinfeld, N | 1 |
Chang, CM; Hsiao, SH; Liao, LH; Lin, CY; Lin, WL; Tsai, JC; Wu, TJ | 1 |
Al-Hommos, NA; Bakri, FG; Cui, L; Hiramatsu, K; Naffa, RG; Shehabi, A | 1 |
Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Vittoria, AD | 1 |
Liu, LZ; McCollum, M; Sorensen, SV | 1 |
Awad, SS; Berger, DH; Elhabash, SI; Farrow, B; Lee, L | 1 |
Abrahamian, FM; Moran, GJ | 1 |
Davis, SL; Delgado, G; Hall, LM; McKinnon, PS; Rose, W; Rybak, MJ; Wilson, RF | 1 |
De Cock, E; Duttagupta, S; Resch, A; Schürmann, D; Sorensen, SV | 1 |
Heymann, WR; Kil, EH; Weinberg, JM | 1 |
Swanston, WH | 1 |
Hitomi, S; Kimura, S; Mori, N; Okuzumi, K; Sugishita, C; Yoneyama, A | 1 |
Castelnovo, C; De Vecchi, A; Guerra, L; Ponticelli, C; Scalamogna, A | 1 |
Dunsmuir, R; Garden, OJ; McKee, R; Whitby, M | 1 |
10 review(s) available for vancomycin and Infections, Staphylococcal Skin
Article | Year |
---|---|
MRSA in Croatia: prevalence and management.
Topics: Animals; Anti-Bacterial Agents; Carrier State; Cattle; Croatia; Daptomycin; Humans; Linezolid; Livestock; Methicillin-Resistant Staphylococcus aureus; Minocycline; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Swine; Teicoplanin; Tigecycline; Vancomycin; Zoonoses | 2016 |
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
Topics: Acetamides; Cost-Benefit Analysis; Decision Support Techniques; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2010 |
Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Female; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Vascular Diseases | 2012 |
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2012 |
[Pathogenetic significance of methicillin resistant Staphylococcus aureus (MRSA) in chronic wounds].
Topics: Bacteriological Techniques; Chronic Disease; Combined Modality Therapy; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin; Wound Infection | 2003 |
The role of vancomycin in the treatment paradigm.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Failure; Vancomycin | 2006 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 3: Clinical management.
Topics: Acetamides; Algorithms; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Skin Infections; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
15 trial(s) available for vancomycin and Infections, Staphylococcal Skin
Article | Year |
---|---|
The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections.
Topics: Acute Disease; Anti-Bacterial Agents; Double-Blind Method; Humans; Incidence; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2019 |
The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Oxazolidinones; Prospective Studies; Staphylococcal Skin Infections; Vancomycin | 2013 |
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2013 |
Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysis.
Topics: Acetamides; Aged; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Skin; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2014 |
Randomized Controlled Noninferiority Trial Comparing Daptomycin to Vancomycin for the Treatment of Complicated Skin and Skin Structure Infections in an Observation Unit.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Emergency Service, Hospital; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2015 |
Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Skin Infections; Vancomycin | 2017 |
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational tr
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Double-Blind Method; Electrophoresis, Gel, Pulsed-Field; Exotoxins; Female; Humans; Internationality; Leukocidins; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Polymerase Chain Reaction; Prognosis; Severity of Illness Index; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2009 |
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
Topics: Acetamides; Americas; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Europe; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Oxazolidinones; Soft Tissue Infections; South Africa; Staphylococcal Skin Infections; Vancomycin | 2010 |
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2010 |
ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2010 |
Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections.
Topics: Aged; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2012 |
Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Daptomycin; Female; Humans; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2013 |
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Americas; Anti-Bacterial Agents; Anti-Infective Agents; Asia; Europe; Female; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin; Methicillin Resistance; Middle Aged; New Zealand; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Daptomycin; Female; Hospital Costs; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition?
Topics: Catheterization; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Parenteral Nutrition; Prospective Studies; Random Allocation; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1985 |
58 other study(ies) available for vancomycin and Infections, Staphylococcal Skin
Article | Year |
---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2009 |
Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Fibroblasts; Humans; Male; Mice; Pyrrolidinones; Staphylococcal Skin Infections; Tenuazonic Acid | 2009 |
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Boron Compounds; Boronic Acids; Endopeptidase Clp; Female; Glycine; Humans; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Peptidomimetics; Protein Binding; Serine Proteinase Inhibitors; Skin; Small Molecule Libraries; Staphylococcal Skin Infections; Structure-Activity Relationship; Virulence | 2020 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant
Topics: Aged; Animals; Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Colony Count, Microbial; Drug Therapy, Combination; Humans; Liposomes; Lysostaphin; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Skin Infections; Vancomycin | 2019 |
New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; ErbB Receptors; Matrix Metalloproteinase 13; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Staphylococcal Skin Infections; Staphylococcus aureus; Surgical Wound Infection; Teicoplanin; Vancomycin; Vascular Endothelial Growth Factor A; Wound Healing | 2020 |
A therapeutic polyelectrolyte-vitamin C nanoparticulate system in polyvinyl alcohol-alginate hydrogel: An approach to treat skin and soft tissue infections caused by Staphylococcus aureus.
Topics: Alginates; Animals; Anti-Bacterial Agents; Ascorbic Acid; Cell Line; Drug Compounding; Drug Liberation; Fibroblasts; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Mice; Nanoparticles; Permeability; Polyesters; Polyvinyl Alcohol; Skin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Swine; Tissue Culture Techniques; Vancomycin | 2017 |
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection | 2013 |
First imported case of skin infection caused by PVL-positive ST30 community-associated methicillin-resistant Staphylococcus aureus clone in a returning Korean traveler from the Philippines.
Topics: Adult; Bacterial Toxins; Carbuncle; Cephalosporins; Community-Acquired Infections; Exotoxins; Female; Humans; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Philippines; Republic of Korea; Staphylococcal Skin Infections; Travel; Vancomycin | 2013 |
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood; Cross Infection; Echocardiography; Female; Hospital Mortality; Humans; Infectious Disease Medicine; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organizational Policy; Practice Guidelines as Topic; Referral and Consultation; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Europe; Female; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Patient Discharge; Practice Guidelines as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Disseminated botryomycosis: a rare presentation.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arm; Diagnosis, Differential; Face; Female; Humans; Infusions, Intravenous; Severity of Illness Index; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2014 |
Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Bacterial Toxins; Broadly Neutralizing Antibodies; Disease Models, Animal; Drug Therapy, Combination; Female; Hemolysin Proteins; Linezolid; Mice, Inbred BALB C; Necrosis; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2015 |
Septic pulmonary and cerebral embolism caused by community-associated methicillin-resistant Staphylococcus aureus in a healthy child.
Topics: Adolescent; Anti-Bacterial Agents; Carbuncle; Community-Acquired Infections; Humans; Intracranial Embolism; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pulmonary Embolism; Rifampin; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Diabetes Complications; Europe; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2015 |
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Daptomycin; Diabetes Complications; Europe; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin; Young Adult | 2015 |
[Skin infection by community-acquired methicillin resistant Staphylococcus aureus with familial transmission].
Topics: Abscess; Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Child; Community-Acquired Infections; Drug Therapy, Combination; Emergencies; Family Health; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Parents; Siblings; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Calcinosis universalis in adult-onset dermatomyositis.
Topics: Abscess; Adrenal Cortex Hormones; Aged; Calcinosis; Dermatomyositis; Drainage; Female; Humans; Skin Diseases; Staphylococcal Skin Infections; Vancomycin | 2015 |
Case of ecthyma gangrenosum in which only methicillin-resistant Staphylococcus epidermidis was detected.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Bone Marrow Transplantation; Dermis; Ecthyma; Humans; Iatrogenic Disease; Immunosuppressive Agents; Lymphoma, Mantle-Cell; Male; Methicillin Resistance; Middle Aged; Staphylococcal Skin Infections; Staphylococcus epidermidis; Vancomycin | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Toxins; Catheter-Related Infections; Clindamycin; Community-Acquired Infections; Cross Infection; Erythromycin; Exfoliatins; Exotoxins; Female; Genotype; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Taiwan; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Molecular Epidemiology of Staphylococcus aureus among Patients with Skin and Soft Tissue Infections in Two Chinese Hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; China; Female; Hospitals; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2016 |
Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Dermatitis, Atopic; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin; Young Adult | 2008 |
Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
Topics: Acetamides; Acetaminophen; Analgesics; Anti-Infective Agents; Cellulitis; Diphenhydramine; Drug Combinations; Famotidine; Furosemide; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Oxycodone; Pulmonary Edema; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic.
Topics: Anti-Bacterial Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Computer Simulation; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus; Teicoplanin; Vancomycin | 2008 |
Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Incidence; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2008 |
Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections.
Topics: Adult; Aged; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Databases, Factual; Drug Utilization Review; Female; Hospitalization; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multicenter Studies as Topic; Skin; Staphylococcal Skin Infections; Vancomycin | 2008 |
Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.
Topics: Anti-Bacterial Agents; Cohort Studies; Databases as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Health Care Costs; Hospitalization; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retreatment; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Time Factors; Treatment Outcome; Vancomycin | 2009 |
Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Drug Utilization; Drug Utilization Review; Female; Humans; Inpatients; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Synergism; Guinea Pigs; Microbial Sensitivity Tests; Polysaccharides, Bacterial; Rifampin; Staphylococcal Skin Infections; Staphylococcus epidermidis; Vancomycin; Virulence Factors | 2010 |
Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates.
Topics: Anti-Bacterial Agents; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Vancomycin; Vancomycin Resistance | 2010 |
Daptomycin non-susceptible, vancomycin intermediate methicillin-resistant Staphylococcus aureus ST398 from a chronic leg ulcer, Italy.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Daptomycin; Female; Humans; Italy; Leg Ulcer; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Skin Infections; Vancomycin | 2010 |
Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Hospitals, University; Humans; Inpatients; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Skin Infections; Vancomycin | 2010 |
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Drug Resistance, Bacterial; Enterococcus; Exotoxins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Leukocidins; Lipoglycopeptides; Microbial Sensitivity Tests; Population Surveillance; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus; Staphylococcus aureus; Streptococcus; Vancomycin | 2010 |
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Diabetes Complications; Diabetic Foot; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2011 |
Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance.
Topics: Child; Clindamycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Outpatients; Staphylococcal Skin Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2011 |
Susceptibility of Staphylococcus aureus to vancomycin: analysis of minimum inhibitory concentrations in two tertiary care hospitals in eastern South Dakota.
Topics: Anti-Bacterial Agents; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Soft Tissue Infections; South Dakota; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2011 |
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.
Topics: Age Factors; Aztreonam; Bacterial Toxins; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Exotoxins; Female; Genotype; Humans; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2012 |
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase IV as Topic; Female; Humans; Infusions, Intravenous; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Oxazolidinones; Propensity Score; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2012 |
Vancomycin-induced DRESS with evidence of T-cell activation in a 22-month-old patient.
Topics: Drug Hypersensitivity; Eosinophilia; Female; Humans; Infant; Lymphocyte Activation; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Skin Infections; T-Lymphocytes; Vancomycin | 2012 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.
Topics: Abscess; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Daptomycin; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mutation; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Staphylococcal Skin Infections; Vancomycin | 2013 |
Oritavancin retains bactericidal activity in vitro against standard and high inocula of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA).
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2013 |
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Glycopeptides; Implants, Experimental; Male; Microbial Sensitivity Tests; Oligopeptides; Polyethylene Terephthalates; Proteins; Rats; Rats, Wistar; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Subcutaneous Tissue; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2003 |
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].
Topics: Aged; Aged, 80 and over; Bacteriological Techniques; Chronic Disease; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Foot Ulcer; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Penicillin Resistance; Pressure Ulcer; Radiodermatitis; Skin Diseases, Bacterial; Skin Ulcer; Staphylococcal Skin Infections; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vancomycin Resistance; Varicose Ulcer; Wound Infection | 2004 |
Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Disease Outbreaks; Disease Transmission, Infectious; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Risk Factors; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin | 2004 |
Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.
Topics: Adolescent; Adult; Aged; Daptomycin; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillins; Staphylococcal Skin Infections; Vancomycin | 2005 |
Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
Topics: Anti-Bacterial Agents; Cross Reactions; Female; Humans; Leukocyte Count; Middle Aged; Neutropenia; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Persistent bacteraemia due to methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in a patient with erythrodermic psoriasis.
Topics: Anti-Bacterial Agents; Bacteremia; Humans; Male; Methicillin Resistance; Middle Aged; Psoriasis; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Implants, Experimental; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Oligopeptides; Prosthesis-Related Infections; Rats; Rats, Wistar; Staphylococcal Skin Infections; Subcutaneous Tissue; Vancomycin | 2007 |
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in
Topics: Acetamides; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin | 2007 |
Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Incidence; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2007 |
Methicillin-resistant Staphylococcus aureus infections.
Topics: Anti-Infective Agents; Humans; Methicillin Resistance; Staphylococcal Skin Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2007 |
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Germany; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Methicillin resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cause of Death; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Hand Disinfection; Hospitals, General; Humans; Intensive Care Units; Methicillin Resistance; Patient Isolation; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Surgery Department, Hospital; Surgical Wound Infection; Trinidad and Tobago; Vancomycin | 1999 |
Susceptibility to vancomycin of methicillin-resistant Staphylococcus aureus isolated in a university hospital in Japan.
Topics: Aged; Drug Resistance, Microbial; Female; Hospitals, University; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2000 |
Staphylococcus aureus exit-site and tunnel infection in CAPD.
Topics: Catheters, Indwelling; Debridement; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Povidone-Iodine; Rifampin; Staphylococcal Skin Infections; Vancomycin | 1990 |